Daiichi Sankyo is a global pharmaceutical company with corporate origins in Japan. Daiichi Sankyo provides innovative products and services in more than 20 countries around the world. With more than 100 years of scientific expertise, the company draws upon a rich legacy of innovation and a robust pipeline of promising new medicines to help patients.
www.daiichi-sankyo.eu Daiichi Sankyo supports the Cardio Update Europe 2022 as a Partner.
Medtronic is the global leader medical technology, alleviating pain, restoring health an extending life for millions of people around the world. With deep roots in the treatment of heart disease, Medtronic now provides a wide range of products and therapies - every three seconds, another life is improved by a Medtronic product or therapy.
www.medtronic.com Medtronic supports the Cardio Update Europe 2022 as a Partner.
Boehringer Ingelheim is driven by the desire to serve humankind by improving human and animal health. As a successful, family owned company BI plans in generations. They work together globally and with integrity.
www.boehringer-ingelheim.com Boehringer Ingelheim supports the Cardio Update Europe 2022 as a Partner.
Servier is specialized in medicinal products. The primary focus is and always has been researching, developing, fine-tuning, and marketing innovative therapeutics, also known as brand-name medicines.
www.servier.com Servier supports the Cardio Update Europe 2022 as a Partner.
At Janssen, they're creating a future where disease is a thing of the past. They’re the Pharmaceutical Companies of Johnson & Johnson, working tirelessly to make that future a reality for patients everywhere by fighting sickness with science, improving access with ingenuity, and healing hopelessness with heart. They focus on areas of medicine where they can make the biggest difference: Cardiovascular & Metabolism, Immunology, Infectious Diseases & Vaccines, Neuroscience, Oncology and Pulmonary Hypertension.
www.janssen.com Janssen supports the Cardio Update Europe 2022 as a Partner.
